Literature DB >> 28053726

PRES with asymptomatic spinal cord involvement. Is this scenario more common than we know?

L C P Marrone1, W A Martins1, J P F Brunelli1, H Fussiger1, G F Carvalhal1, J R H Filho1, R B Soder1, M Schuck1, F S Viola1, A C H Marrone1, J C da Costa1.   

Abstract

INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is an entity characterized by neurologic symptoms such as headaches, altered mental status, seizures and visual changes, and it is associated with white matter vasogenic edema predominantly affecting the posterior occipital and parietal lobes of the brain. CASE REPORT: A 19-year-old patient developed PRES after the use of chemotherapy for a testicular teratocarcinoma and after the development of a blood pressure elevation. DISCUSSION: Few cases described the involvement of the spinal cord in this syndrome. In the majority of these cases, the spinal cord involvement was asymptomatic or with few symptoms of spinal cord disease.

Entities:  

Year:  2016        PMID: 28053726      PMCID: PMC5125063          DOI: 10.1038/scsandc.2015.1

Source DB:  PubMed          Journal:  Spinal Cord Ser Cases        ISSN: 2058-6124


  20 in total

1.  [Posterior reversible encephalopathy syndrome (pres) in sepsis].

Authors:  C de Haro; R Ferrer; A Tercero; J Vallés
Journal:  Med Intensiva       Date:  2012-04-27       Impact factor: 2.491

2.  Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome.

Authors:  Marcelo Matiello; Setty M Magana; Brian G Weinshenker
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

3.  Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

Authors:  W S Bartynski; J F Boardman; Z R Zeigler; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

4.  Neurological picture. Spinal cord involvement in posterior reversible encephalopathy syndrome.

Authors:  B Lapuyade; I Sibon; S Jeanin; V Dousset
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-01       Impact factor: 10.154

5.  Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome.

Authors:  C Briganti; M Caulo; F Notturno; A Tartaro; A Uncini
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

6.  Posterior reversible encephalopathy syndrome (PRES) and systemic lupus erythematosus: report of two cases.

Authors:  Luis Marrone; Aline de Souza Streck; Henrique Luiz Staub; Caroline Zechlinski Xavier de Freitas; Jaderson Costa; Giovani Gadonski; Henrique Luiz Staub
Journal:  Rev Bras Reumatol       Date:  2012-10

Review 7.  Cerebral autoregulation.

Authors:  O B Paulson; S Strandgaard; L Edvinsson
Journal:  Cerebrovasc Brain Metab Rev       Date:  1990

8.  Posterior reversible encephalopathy syndrome with spinal cord involvement.

Authors:  Adam de Havenon; Zachary Joos; Loren Longenecker; Lubdha Shah; Safdar Ansari; Kathleen Digre
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

9.  Posterior reversible encephalopathy syndrome in liver transplant patients: clinical presentation, risk factors and initial management.

Authors:  R J Cruz; A DiMartini; M Akhavanheidari; N Iacovoni; J F Boardman; J Donaldson; A Humar; W S Bartynski
Journal:  Am J Transplant       Date:  2012-04-11       Impact factor: 8.086

10.  Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy.

Authors:  Luiz Carlos Porcello Marrone; Bianca Fontana Marrone; Tharick Ali Pascoal; Lucas Porcello Schilling; Ricardo Bernardi Soder; Sheila Schuch Ferreira; Giovani Gadonski; Jaderson Costa da Costa
Journal:  Case Rep Oncol Med       Date:  2013-02-27
View more
  2 in total

1.  Spinal cord lesions in a pediatric patient with chronic kidney disease and review of literature: Answers.

Authors:  Harmanpreet Tiwana; Himadri Patel; Sheila Asghar; Ashutosh Kumar; Michael Freeman
Journal:  Pediatr Nephrol       Date:  2018-11-15       Impact factor: 3.714

2.  Posterior reversible encephalopathy syndrome, a clinically diverse and challenging disorder.

Authors:  Therese Chruickshank; Hanne Thoresen; Espen Benjaminsen; Francis Odeh
Journal:  Clin Case Rep       Date:  2020-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.